Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Whitbourn

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
JACC. Cardiovascular Interventions|November 21, 2015
Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)Yuki Ishibashi, Shimpei Nakatani, Yohei Sotomi, et al.
Circulation|February 11, 2004
Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trialPatrick W Serruys, Muzaffer Degertekin, Kengo Tanabe, et al.
Journal of the American College of Cardiology|February 20, 2016
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-UpPatrick W Serruys, John Ormiston, Robert-Jan van Geuns, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 2, 2011
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trialSalvatore Brugaletta, Josep Gomez-Lara, Nico Bruining, et al.
European Heart Journal|December 3, 2010
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffoldsJosep Gomez-Lara, Salvatore Brugaletta, Roberto Diletti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 29, 2014
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical TrialChristos V Bourantas, Vasim Farooq, Yaojun Zhang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 5, 2010
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trialsKatsuhisa Waseda, Takao Hasegawa, Junya Ako, et al.
Journal of the American College of Cardiology|May 25, 2010
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trialDean J Kereiakes, Louis A Cannon, Robert L Feldman, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 28, 2011
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-studyJosep Gomez-Lara, Roberto Diletti, Salvatore Brugaletta, et al.
The International Journal of Cardiovascular Imaging|November 24, 2011
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Josep Gomez-Lara, Hector M Garcia-Garcia, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
JACC. Cardiovascular Interventions|November 21, 2015
Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)Yuki Ishibashi, Shimpei Nakatani, Yohei Sotomi, et al.
Circulation|February 11, 2004
Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trialPatrick W Serruys, Muzaffer Degertekin, Kengo Tanabe, et al.
Journal of the American College of Cardiology|February 20, 2016
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-UpPatrick W Serruys, John Ormiston, Robert-Jan van Geuns, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 2, 2011
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trialSalvatore Brugaletta, Josep Gomez-Lara, Nico Bruining, et al.
European Heart Journal|December 3, 2010
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffoldsJosep Gomez-Lara, Salvatore Brugaletta, Roberto Diletti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 29, 2014
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical TrialChristos V Bourantas, Vasim Farooq, Yaojun Zhang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 5, 2010
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trialsKatsuhisa Waseda, Takao Hasegawa, Junya Ako, et al.
Journal of the American College of Cardiology|May 25, 2010
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trialDean J Kereiakes, Louis A Cannon, Robert L Feldman, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 28, 2011
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-studyJosep Gomez-Lara, Roberto Diletti, Salvatore Brugaletta, et al.
The International Journal of Cardiovascular Imaging|November 24, 2011
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Josep Gomez-Lara, Hector M Garcia-Garcia, et al.
Pageof 10